Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maiko Ikenouchi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|November 12, 2023
[Advances in biomarkers and clinical applications in inflammatory bowel disease]Shinichiro Shinzaki, Maiko Ikenouchi, Koji Kamikozuru
World Journal of Gastroenterology|March 30, 2016
Ileus caused by cholesterol crystal embolization: A case reportShunjiro Azuma, Maiko Ikenouchi, Takuji Akamatsu, et al.
United European Gastroenterology Journal|November 13, 2024
Real-World Comparative Effectiveness and Safety of Filgotinib and Upadacitinib for Ulcerative Colitis: A Multicentre Cohort StudyAkira Nogami, Kunio Asonuma, Shinji Okabayashi, et al.
Endoscopy International Open|September 20, 2017
Effectiveness and safety of metallic stent for ileocecal obstructive colon cancer: a report of 4 casesTatsuya Ishii, Kosuke Minaga, Satoshi Ogawa, et al.
European Journal of Gastroenterology & Hepatology|August 14, 2023
Efficacy of antimicrobial therapy in patients with uncomplicated acute colonic diverticulitis: an updated systematic review and meta-analysisTakeshi Seta, Hiroyoshi Iwagami, Nobukazu Agatsuma, et al.
World Journal of Gastroenterology|April 25, 2024
Real-world efficacy and safety of tofacitinib treatment in Asian patients with ulcerative colitisKentaro Kojima, Kenji Watanabe, Mikio Kawai, et al.
Intestinal Research|February 2, 2025
Propensity score-matched real-world comparative treatment outcomes of Janus kinase inhibitors for ulcerative colitis in patients with and without prior exposure to anti-tumor necrosis factor α antibodyMaiko Ikenouchi, Hirokazu Fukui, Soichi Yagi, et al.
Journal of Clinical Medicine|January 11, 2025
Continuous Treatment with Tofacitinib but Not Filgotinib Is Effective in Non-Responders with Active Ulcerative Colitis: A Propensity Score-Matching AnalysisSoichi Yagi, Hirokazu Fukui, Maiko Ikenouchi, et al.
International Journal of Molecular Sciences|October 16, 2025
Effect of Chronic Social Defeat Stress on the Small-Intestinal Environment, Including the Gut Flora, Immune System, and Mucosal Barrier IntegritySoichi Yagi, Hirokazu Fukui, Tetsuya Shiraishi, et al.
Journal of Clinical Medicine|August 14, 2025
Comparative Effectiveness of Ustekinumab and Vedolizumab as Maintenance Therapy After Tacrolimus-Induced Improvement in Patients with Acute Severe Ulcerative Colitis: A Retrospective Cohort StudyKoji Kaku, Toshiyuki Sato, Jiro Takeuchi, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|November 12, 2023
[Advances in biomarkers and clinical applications in inflammatory bowel disease]Shinichiro Shinzaki, Maiko Ikenouchi, Koji Kamikozuru
World Journal of Gastroenterology|March 30, 2016
Ileus caused by cholesterol crystal embolization: A case reportShunjiro Azuma, Maiko Ikenouchi, Takuji Akamatsu, et al.
United European Gastroenterology Journal|November 13, 2024
Real-World Comparative Effectiveness and Safety of Filgotinib and Upadacitinib for Ulcerative Colitis: A Multicentre Cohort StudyAkira Nogami, Kunio Asonuma, Shinji Okabayashi, et al.
Endoscopy International Open|September 20, 2017
Effectiveness and safety of metallic stent for ileocecal obstructive colon cancer: a report of 4 casesTatsuya Ishii, Kosuke Minaga, Satoshi Ogawa, et al.
European Journal of Gastroenterology & Hepatology|August 14, 2023
Efficacy of antimicrobial therapy in patients with uncomplicated acute colonic diverticulitis: an updated systematic review and meta-analysisTakeshi Seta, Hiroyoshi Iwagami, Nobukazu Agatsuma, et al.
World Journal of Gastroenterology|April 25, 2024
Real-world efficacy and safety of tofacitinib treatment in Asian patients with ulcerative colitisKentaro Kojima, Kenji Watanabe, Mikio Kawai, et al.
Intestinal Research|February 2, 2025
Propensity score-matched real-world comparative treatment outcomes of Janus kinase inhibitors for ulcerative colitis in patients with and without prior exposure to anti-tumor necrosis factor α antibodyMaiko Ikenouchi, Hirokazu Fukui, Soichi Yagi, et al.
Journal of Clinical Medicine|January 11, 2025
Continuous Treatment with Tofacitinib but Not Filgotinib Is Effective in Non-Responders with Active Ulcerative Colitis: A Propensity Score-Matching AnalysisSoichi Yagi, Hirokazu Fukui, Maiko Ikenouchi, et al.
International Journal of Molecular Sciences|October 16, 2025
Effect of Chronic Social Defeat Stress on the Small-Intestinal Environment, Including the Gut Flora, Immune System, and Mucosal Barrier IntegritySoichi Yagi, Hirokazu Fukui, Tetsuya Shiraishi, et al.
Journal of Clinical Medicine|August 14, 2025
Comparative Effectiveness of Ustekinumab and Vedolizumab as Maintenance Therapy After Tacrolimus-Induced Improvement in Patients with Acute Severe Ulcerative Colitis: A Retrospective Cohort StudyKoji Kaku, Toshiyuki Sato, Jiro Takeuchi, et al.
Pageof 2